Skip to main content
Clinical Trials/NCT00450034
NCT00450034
Completed
N/A

Impact of Optimization of Drug Treatment of Elderly Admitted in 4 Acute Geriatric Wards : Randomized Trial

Assistance Publique - Hôpitaux de Paris1 site in 1 country665 target enrollmentApril 2007

Overview

Phase
N/A
Intervention
Not specified
Conditions
Global Medical Assessment of Elderly Frail Patients
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
665
Locations
1
Primary Endpoint
Rate of unplanned readmissions, including emergency consultations,
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

A randomized trial has been designed to determine if this complex intervention can significantly decrease the risk of unplanned readmissions in this very elderly population, compared with usual care.

Detailed Description

Drug treatment in elderly is not yet optimal. 20 to 30% of admissions of elderly aged over 80 are related to drug problems, most of them being preventable. To decrease drug related hospitalizations need iatrogenic prevention, compliance improvement, and underuse decrease. A multifaceted intervention has been designed, included three dimensions : 1/ drug optimization 2/ patient and/or caregiver education and 3/ better coordination with home health professionals before discharge. A randomized trial has been designed to determine if this complex intervention can significantly decrease the risk of unplanned readmissions in this very elderly population, compared with usual care.

Registry
clinicaltrials.gov
Start Date
April 2007
End Date
June 2009
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients hospitalized as a matter of urgency in unity(unit) of geriatrics acute
  • Patients of more than 70 years old
  • Hospitalization in the Unity(Unit) of Geriatrics foreseen(planned) superior acute in 5 days
  • enlightened assent writing and signed
  • preliminary medical examination

Exclusion Criteria

  • Patients in scheduled(programmed) hospitalization
  • Patient in palliative care
  • Patient whose vital forecast is engaged(opened) in 3 months
  • Patient already include during a previous hospitalization Patient already included in a study concerning the therapeutic care
  • Followed medical impossible (refusal of care, absence of alive regular, patient doctor abroad)
  • not membership to a regime of Social Security or CMU
  • Patient not speaking French

Outcomes

Primary Outcomes

Rate of unplanned readmissions, including emergency consultations,

Time Frame: during the study

Secondary Outcomes

  • Mortality at 6 months,(at 6 months)
  • delay before readmission,(before readmission)
  • number of drug events related readmissions.(readmissions)
  • Data collected at 3 and 6 months(at 3 and 6 months)

Study Sites (1)

Loading locations...

Similar Trials